{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:21Z","timestamp":1786120221828,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/adm.0b013e318233d64b","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T08:56:33Z","timestamp":1319878593000},"page":"248-253","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of Comorbid Substance Use and Anxiety Disorders"],"prefix":"10.1097","volume":"5","author":[{"given":"Richard","family":"Ries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate B.","family":"Wolitzky-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim T.","family":"Operskalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle G.","family":"Craske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Roy-Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-244X-7-29","article-title":"Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients.","volume":"7","author":"Bakken","year":"2007","journal-title":"BMC Psychiatry"},{"issue":"3","key":"R2-2-20210126","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1891\/jcop.2005.19.3.261","article-title":"A critical look at dual-focused cognitive-behavioral treatments for comorbid substance use and psychiatric disorders: strengths, limitations, and future directions.","volume":"19","author":"Conrod","year":"2005","journal-title":"J Cogn Psychother"},{"issue":"9","key":"R5-2-20210126","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: a prospective study.","volume":"57","author":"Gelpin","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R6-2-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.comppsych.2009.07.005","article-title":"Moderators and mediators among panic, agoraphobia symptoms, and suicidal ideation in patients with panic disorder.","volume":"51","author":"Huang","year":"2010","journal-title":"Compr Psychiatry"},{"issue":"2","key":"R7-2-20210126","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10550490290087910","article-title":"The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.","volume":"11","author":"Malcolm","year":"2002","journal-title":"Am J Addict"},{"issue":"1","key":"R8-2-20210126","first-page":"24","article-title":"Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.","volume":"3","author":"Malcolm","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"R9-2-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.npp.1301544","article-title":"Neuroplasticity mediated by altered gene expression.","volume":"33","author":"McClung","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"R10-2-20210126","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4088\/JCP.v63n1214h","article-title":"Hypnotic medication in the aftermath of trauma.","volume":"63","author":"Mellman","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"R11-2-20210126","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"R12-2-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archgenpsychiatry.2010.131","article-title":"Postdisaster course of alcohol use disorders in systematically studied survivors of 10 disasters.","volume":"68","author":"North","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"R13-2-20210126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1521-0391.1998.tb00337.x","article-title":"Use of anticonvulsants in benzodiazepine withdrawal.","volume":"7","author":"Pages","year":"1998","journal-title":"Am J Addict"},{"issue":"7","key":"R14-2-20210126","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","article-title":"The pharmacologic treatment of anxiety disorders: a review of progress.","volume":"71","author":"Ravindran","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"R15-2-20210126","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1993.01820230054005","article-title":"Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.","volume":"50","author":"Rickels","year":"1993","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"R16-2-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.1991.10472575","article-title":"Benzodiazepine withdrawal: clinicians ratings of carbamazepine treatment versus traditional taper methods.","volume":"23","author":"Ries","year":"1991","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"R18-2-20210126","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/ajp.146.4.536","article-title":"Carbamazepine treatment for benzodiazepine withdrawal.","volume":"146","author":"Ries","year":"1989","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:08Z","timestamp":1786048088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01271255-201112000-00002"}},"subtitle":["A Case Study"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e318233d64b","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}